Greg Sieczkiewicz

Greg is a trusted intellectual property strategy advisor for entrepreneurs, venture capital firms, emerging start-ups, and public biotech/pharmaceutical companies. Over the past 20 years, he has contributed to the creation, execution, assertion and defense of strategic legal plans for a diverse array of biotechnology companies. In addition, he has been the front line agreement negotiator and drafter for licensing, development and commercialization agreements relating to biologics and small molecules from pre-IND to approved drugs. Greg was awarded a PhD in cell, molecular and developmental biology from the Tufts Graduate School of Biomedical Sciences, a law degree from Suffolk University Law School, and an undergraduate degree from the College of the Holy Cross. Greg has been affiliated with top law firms including Mintz Levin, Proskauer Rose, and Foley Hoag. Greg is currently the Chief IP Counsel at MPM Capital, and was previously Vice President of IP at Flagship Pioneering.